Patent · US Active

Anti-CEA antibodies

US8642742B2 · kind B2 · utility

20Cited by
16References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 29, 2012
Grant dateFeb 4, 2014
Priority date—
Expiry dateFeb 29, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides antigen binding molecules (ABMs) which bind membrane-bound CEA, including ABMs with improved therapeutic properties, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.